N Sarita Shah

Dados Biográficos

ID9066181
NOMEN Sarita Shah
PRENOMESN Sarita
SOBRENOMEShah
ASSINATURASHAH N S
AFILIAÇÕESDepartment of Epidemiology, Emory Rollins School of Public Health, Atlanta, Georgia, USA
ORCID0000-0001-6069-0857
VERIFICADOSim
TOTAL DE OBRAS7
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR1
TOTAL COMO EDITOR6
PRIMEIRO ANO DE PUBLICAÇÃO2024
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0

  • The implementation of tuberculosis preventive therapy in HIV care clinics in Africa, Asia and Latin America

    Open AccessRemo Schmutz, Nicolas Banholzer et al.ARTICLEBMJ Global Health2026

    INTRODUCTION: Towards the 'End TB Strategy' targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years after the release of the updated 2020 WHO guidelines, we investigated the implementation of TPT services at HIV clinics in low-income and middle-income countries (LMICs), focusing on TB screening, populations eligible for TPT and available TPT regi…

  • Qualitative study of acceptability, benefits, and feasibility of a food-based intervention among participants and stakeholders of the Rations trial

    Open AccessSunita Sheel Bandewar, Madhavi Bhargava et al.ARTICLEPLOS Global Public Health2025

    A qualitative study was conducted during the RATIONS trial to explore the perceptions, experiences, and expectations of participants and stakeholders on the acceptability, benefits, and feasibility of the nutritional intervention to complement the trial findings for deeper exploration into why and how of these findings and other allied themes. Using purposive sampling, we recruited 58 individuals for 22 in-depth interviews (IDI) and four focus gr…

  • Persistently high TB prevalence in Nairobi County neighbourhoods, 2015–2022

    Open AccessJane Rahedi Ong’ang’o, Jennifer M Ross et al.ARTICLEPLOS Global Public Health2025

    National and sub-national population-based surveys, when performed at intervals, may assess important changes in TB prevalence. In 2022 we re-surveyed nine Nairobi County neighbourhoods that were previously surveyed in 2015. We aimed to determine pulmonary TB prevalence, compare prevalence to 2015 estimates, and evaluate changes in risk groups. Participants who reported cough of any duration and/or whose chest x-ray suggested TB submitted sputum …

  • End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine

    Open AccessVini Fardhdiani, Olena Trush et al.ARTICLEPLOS Global Public Health2025

    The World Health Organization has called for operational research on all-oral shorter regimens for rifampin-resistant and multidrug-resistant forms of tuberculosis (RR/MDR-TB). We followed a cohort of patients in Zhytomyr, Ukraine for effectiveness, safety, tolerability and feasibility of bedaquiline & delamanid-based treatment regimens under programmatic conditions. This was a single-arm implementation study. All consenting persons with RR/MDR-T…

  • Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings

    Open AccessEdson Marambire, Claire Jacqueline Calderwood et al.ARTICLEPLOS Global Public Health2025

    Tuberculosis household contacts are at high risk of developing tuberculosis. Tuberculosis preventive therapy (TPT) is highly effective, but implementation is hindered by limited accessibility of diagnostic tests aimed at detecting Mycobacterium tuberculosis ( Mtb) infection. Development of Mtb infection prediction models to guide clinical decision-making aims to overcome these challenges. We used data from 1905 tuberculosis household contacts (ag…

  • Mortality and loss to follow-up among Tuberculosis patients on treatment in Meru County, Kenya

    Open AccessMoses M Ngari, Jane K Mberia et al.ARTICLEPLOS Global Public Health2025

    Tuberculosis (TB) remains a leading cause of death globally. Patients who get lost to follow-up (LTFU) during TB treatment have high risk of relapse, mortality, treatment failure and developing Multidrug resistant TB. Empirical data to monitor long-term TB treatment outcomes in low-and-middle income countries (LMICs) are sparse. We determined proportion of TB patients who die or are LTFU during six months of treatment and identified factors indep…

  • Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort

    Open AccessJocelyn Jansen van Vuuren, Tim Crocker-Buque et al.ARTICLEPLOS Global Public Health2024

    Tuberculosis (TB) and chronic hepatitis C virus infection (HCV) remain significant global health challenges, especially in low- and middle-income countries. In Eastern Europe, a considerable percentage of multi-drug resistant (MDR) and rifampicin resistant (RR) TB populations show high HCV prevalence. Current WHO guidelines do not routinely advise HCV testing during MDR-TB treatment, despite HCV being a risk factor for drug-induced liver complica…